Since the Covid pandemic began in 2020, the FDA has shuttered its White Oak, MD, doors to outside companies not only seeking input on their developing assets, but for adcomm meetings too.
As of today, the FDA says nothing is changing in the near term with respect to a re-opening, although the agency has updated how it defines in-person meetings to include Zoom meetings with cameras on.
“This means face-to-face meetings will only be virtual at this time,” the agency said in a statement. “Once FDA returns to in-person meetings, sponsors/applicants will be notified of that option for a face-to-face meeting.”
Read Again https://news.google.com/__i/rss/rd/articles/CBMiVmh0dHBzOi8vZW5kcHRzLmNvbS9hbGxvZ2VuZS1jb21wbGV0ZXMtc2hhbmdoYWktZmFjaWxpdHktdG8tbWFudWZhY3R1cmUtY2FyLXQtcHJvZHVjdHMv0gEA?oc=5
Bagikan Berita Ini
0 Response to "Allogene Overland Biopharm completes Shanghai facility to manufacture CAR-T products - Endpoints News"
Post a Comment